0001193125-22-244278.txt : 20220914 0001193125-22-244278.hdr.sgml : 20220914 20220914080102 ACCESSION NUMBER: 0001193125-22-244278 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220913 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220914 DATE AS OF CHANGE: 20220914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc. CENTRAL INDEX KEY: 0001813814 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40360 FILM NUMBER: 221242094 BUSINESS ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 BUSINESS PHONE: (212) 220-6633 MAIL ADDRESS: STREET 1: 1166 ALBERNI STEET STREET 2: SUITE 1604 CITY: VANCOUVER STATE: A1 ZIP: V6E 3Z3 8-K 1 d404439d8k.htm 8-K 8-K
false 0001813814 0001813814 2022-09-13 2022-09-13

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 13, 2022

 

 

Mind Medicine (MindMed) Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

British Columbia, Canada   001-40360   98-1582438
(State or Other Jurisdiction
of Incorporation)		  

(Commission

File Number)

   (IRS Employer
Identification No.)

 

One World Trade Center, Suite 8500

New York, New York

   10007
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (650) 208-2454

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Shares   MNMD   The NASDAQ Stock Market LLC

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 

Item 8.01

Other Events.

On September 14, 2022, Mind Medicine (MindMed) Inc. (the “Company”) issued a press release announcing that the Company received notice from the Nasdaq Listing Qualifications Office of The Nasdaq Stock Market LLC (“Nasdaq”) on September 13, 2022, indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
Number

   

Description

99.1    Press Release, dated September 14, 2022
104    Cover Page Interactive Data File (formatted as Inline XBRL)

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      MIND MEDICINE (MINDMED) INC.
Date: September 14, 2022     By:  

/s/ Robert Barrow

      Robert Barrow
Chief Executive Officer
 EX-99.1 2 d404439dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

MindMed Announces Compliance with Nasdaq Listing Requirements

NEW YORK, Sept. 14, 2022 — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it has received a letter from The Nasdaq Stock Market LLC advising the Company that it has regained compliance with Nasdaq’s minimum bid price listing requirement. The Company has satisfied the terms for continued listing on the Nasdaq Capital Market by complying with the minimum bid price requirement of $1.00 per share under Nasdaq Listing Rule 5550(a)(2), and all other criteria for continued listing. Accordingly, Nasdaq has advised that the matter is now closed.

The Company believes the completion of the reverse share split and subsequent attainment of compliance with Nasdaq listing requirements enables the Company to potentially achieve several important corporate objectives, including but not limited to, the ability to meet certain security eligibility criteria for consideration for inclusion into market-wide and healthcare sector indices, potentially augment MindMed’s visibility within the investment community, increase the liquidity of its common shares and broaden its shareholder base.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine, and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

Forward-Looking Statements

Certain statements in this news release related to the Company constitute “forward-looking information” within the meaning of applicable securities laws and are prospective in nature. Forward-looking information is not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as “will”, “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe”, “potential” or “continue”, or the negative thereof or similar variations. Forward-looking information in this news release include, but are not limited to, statements regarding the Company’s ability to continue to meet the listing standards on

LOGO

 

NASDAQ, to achieve anticipated upcoming milestones and corporate objectives, meet securities eligibility criteria for inclusion in market-wide and healthcare sector indices, increase liquidity for its common shares and broaden its shareholder base.. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including history of negative cash flows; limited operating history; incurrence of future losses; availability of additional capital; lack of product revenue; compliance with laws and regulations; difficulty associated with research and development; risks associated with clinical trials or studies; heightened regulatory scrutiny; early stage product development; clinical trial risks; regulatory approval processes; novelty of the psychedelic inspired medicines industry; as well as those risk factors discussed or referred to herein and the risks described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and its Quarterly Reports on Form 10-Q for the period ended June 30, 2022 under headings such as “Special Note Regarding Forward-Looking Statements,” and “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other filings and furnishings made by the Company with the securities regulatory authorities in all provinces and territories of Canada which are available under the Company’s profile on SEDAR at www.sedar.com and with the U.S. Securities and Exchange Commission on EDGAR at www.sec.gov. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, changes in expectations or otherwise.

For Media: media@mindmed.co

For Investors: ir@mindmed.co

EX-101.SCH 3 mnmd-20220913.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 mnmd-20220913_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key EX-101.PRE 5 mnmd-20220913_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g404439g0914040837775.jpg GRAPHIC begin 644 g404439g0914040837775.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Sep. 13, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 13, 2022
Entity Registrant Name Mind Medicine (MindMed) Inc.
Entity Incorporation, State or Country Code A1
Entity File Number 001-40360
Entity Tax Identification Number 98-1582438
Entity Address, Address Line One One World Trade Center
Entity Address, Address Line Two Suite 8500
Entity Address, City or Town New York
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10007
City Area Code 650
Local Phone Number 208-2454
Title of 12(b) Security Common Shares
Trading Symbol MNMD
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Amendment Flag false
Entity Central Index Key 0001813814
XML 8 d404439d8k_htm.xml IDEA: XBRL DOCUMENT 0001813814 2022-09-13 2022-09-13 false 0001813814 8-K 2022-09-13 Mind Medicine (MindMed) Inc. A1 001-40360 98-1582438 One World Trade Center Suite 8500 New York NY 10007 650 208-2454 Common Shares MNMD NASDAQ false false false false true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d404439d8k.htm d404439dex991.htm mnmd-20220913.xsd mnmd-20220913_lab.xml mnmd-20220913_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d404439d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d404439d8k.htm" ] }, "labelLink": { "local": [ "mnmd-20220913_lab.xml" ] }, "presentationLink": { "local": [ "mnmd-20220913_pre.xml" ] }, "schema": { "local": [ "mnmd-20220913.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 24, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mnmd", "nsuri": "http://imetrix.edgar-online.com/20220913", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d404439d8k.htm", "contextRef": "duration_2022-09-13_to_2022-09-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d404439d8k.htm", "contextRef": "duration_2022-09-13_to_2022-09-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://imetrix.edgar-online.com//20220913/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 15 0001193125-22-244278-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-244278-xbrl.zip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end